17 hours ago To ensure that you are receiving Patient Portal emails please do the following: Add NextMD.com to your contact list, address list, safe list, or "Do Not Block" list. If you are using your own spam filtering software, please be sure that you are not filtering out email from NextMD.com. Account will be locked for 20 minutes after 4 failed login ... >> Go To The Portal
To ensure that you are receiving Patient Portal emails please do the following: Add NextMD.com to your contact list, address list, safe list, or "Do Not Block" list. If you are using your own spam filtering software, please be sure that you are not filtering out email from NextMD.com. Account will be locked for 20 minutes after 4 failed login ...
Step 2: Your doctor orders the test. Chances are your provider knows about AVISE, but if they don't we will get them set-up quickly so they can send in your blood sample for testing. Step 3: Test results will be sent to your physician within 5 business days. Take the Next Step.
For more information please contact our AVISE Patient Advocate Team at (888) 452-1522, option 2. If you have received a check from your insurance company please: Sign the check "pay to the order of Exagen Inc." Include copy of your EOB - explanation of benefit. Mail to: Exagen Inc., PO BOX 27561, Albuquerque NM 87125.
Our ProductsAVISE testing offers next-generation insight to aid the diagnosis, prognosis and monitoring of autoimmune conditions.To learn more about each individual test, click the test name below.Diagnostic TestsA powerful diagnostic tool to help distinguish overlapping symptoms and aid in the differential diagnosis of RA, SLE, fibromyalgia, Sjögren's Syndrome, …
How to get an AVISE Test:Step 1: Download the letter for your physician and bring it to your next appointment. Download Letter.Step 2: Your doctor orders the test. ... Step 3: Test results will be sent to your physician within 5 business days.
AVISE® CTD is a blood test that can help doctors diagnose lupus and other autoimmune diseases — like rheumatoid arthritis, Sjögren's syndrome, or scleroderma.Feb 26, 2019
Exagen provides physicians with advanced testing for accurate and timely diagnosis, prognosis and monitoring of autoimmune conditions.
How long does it take to get results? AVISE CTD results are provided to the ordering physician within 5 business days from receipt of the sample.
High levels of EC4d, B-cell-bound C4d (BC4d) and platelet-bound C4d (PC4d) can differentiate SLE from other CTDs with 56%–72% sensitivity and 80%–98% specificity, and from healthy individuals with 60%–81% sensitivity and 91%–100% specificity.Mar 18, 2020
But there are four kinds of lupus:Systemic lupus erythematosus (SLE), the most common form of lupus.Cutaneous lupus, a form of lupus that is limited to the skin.Drug-induced lupus, a lupus-like disease caused by certain prescription drugs.Neonatal lupus, a rare condition that affects infants of women who have lupus.Oct 21, 2020
AVISE® Lupus is a 10-marker diagnostic test containing Cell-Bound Complement Activation Products (CB-CAPs) and SLE associated markers designed to aid healthcare providers in a timely differential diagnosis of SLE.
It's likely that lupus results from a combination of your genetics and your environment. It appears that people with an inherited predisposition for lupus may develop the disease when they come into contact with something in the environment that can trigger lupus. The cause of lupus in most cases, however, is unknown.Jan 27, 2021
A connective tissue disease is any disease that affects the parts of the body that connect the structures of the body together. Connective tissues are made up of two proteins: collagen and elastin. Collagen is a protein found in the tendons, ligaments, skin, cornea, cartilage, bone and blood vessels.Dec 16, 2019
Vitamin D deficiency may contribute to immune dysregulation resulting in the production of autoantibodies, in particular antinuclear antibodies (ANA) (6, 7).Aug 19, 2016
ACR criteria[1,2]SLICC criteria(4 of 11 criteria)*(4 of 17 criteria, including at least 1 clinical criterion and 1 immunologic criterion;¶ OR biopsy-proven lupus nephritisΔ)Discoid rashChronic cutaneous lupusNonscarring alopeciaOral ulcersOral or nasal ulcers22 more rows
AVISE® SLE Prognostic is a 10-marker panel developed to help assess a patient's potential risk for Thrombosis, Cardiovascular events, Lupus Nephritis and Neuropsychiatric Lupus.
AVISE® Lupus Result : Negative – Index: -5.0. A result is marked as equivocal when one or more critical values is close to a threshold that would significantly change the index value if the threshold was crossed.
The Avise Lupus test had excellent performance characteristics, as compared to the physician's diagnosis, with sensitivity of 83.3%, specificity of 86.4%, positive predictive value of 87.0%, and negative predictive value of 82.6% (positive likelihood ratio: 6.125 and negative likelihood ratio: 0.19).Oct 31, 2016
AVISE® CTD is a blood test that can help doctors diagnose lupus and other autoimmune diseases — like rheumatoid arthritis, Sjögren's syndrome, or scleroderma.Feb 26, 2019
AVISE® Lupus is a 10-marker diagnostic test containing Cell-Bound Complement Activation Products (CB-CAPs) and SLE associated markers designed to aid healthcare providers in a timely differential diagnosis of SLE.
How long does it take to get results? AVISE CTD results are provided to the ordering physician within 5 business days from receipt of the sample. How was AVISE CTD developed and validated? AVISE CTD was developed after 15 years of research by Exagen and collaborators.
AVISE® SLE Prognostic is a 10-marker panel developed to help assess a patient's potential risk for Thrombosis, Cardiovascular events, Lupus Nephritis and Neuropsychiatric Lupus.
But there are four kinds of lupus:Systemic lupus erythematosus (SLE), the most common form of lupus.Cutaneous lupus, a form of lupus that is limited to the skin.Drug-induced lupus, a lupus-like disease caused by certain prescription drugs.Neonatal lupus, a rare condition that affects infants of women who have lupus.Oct 21, 2020
AVISE testing offers leading-edge diagnostic, prognostic and monitoring tools for autoimmune rheumatic diseases such as lupus and rheumatoid arthritis.
AVISE testing offers leading-edge diagnostic, prognostic and monitoring tools for autoimmune rheumatic diseases such as lupus and rheumatoid arthritis.
PHOENIX ( October 13, 2020) – Sonora Quest Laboratories, the market share leader in diagnostic laboratory testing in Arizona, has announced an exclusive partnership with Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. The partnership will expand access to Exagen’s AVISE portfolio of innovative products to rheumatologists and their patients in Arizona.
Sonora Quest Laboratories is accredited by the College of American Pathologists (CAP), which is the gold standard in laboratory accreditation, helping laboratories to maintain accuracy of test results and ensure accurate patient diagnosis.
Some of the more common autoimmune diseases include type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease . The AVISE portfolio offers a unique opportunity to positively impact the health disparities for at risk patients of autoimmune diseases.
Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE® brand, several of which are based on its proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. Exagen’s goal is to enable rheumatologists to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including SLE and rheumatoid arthritis.